of tumorspheres at second (P2) and third passage (P3) (B) Number of P2 and P3 tumorspheres. (C) Number of P2 and P3 tumorspheres by size (D) Relative expression of CD24+CD44+ and CD24+CD44+ESA+ PCSC markers in cells from P2 and P3 tumorspheres (E) Leptin determination in conditioned media. BxPC-3 and Panc-1 cells were cultured in basal conditions (medium containing no leptin) for 24 h and for one week to form tumorspheres (P1, P2 and P3) that were treated as described in Materials and Methods. Tumorsphere number and size were determined using a microscope and PCSC markers were analyzed using flow cytometry. Basal condition (untreated) was used as control (100%). Effects of treatment on tumorspheres and PCSC markers were expressed as % of control. Conditioned media was lyophilized, resuspended and used to determine leptin by ELISA. All experiments were performed in triplicate: a: p ≤ 0.05 compared to control; b: p ≤ 0.05 when compared to leptin; c: p ≤ 0.05 when compared to cells. B = basal; L = leptin (1.2 nM); L+I = leptin (1.2 nM) +IONP-LPrA2 (0.0036 pM); L+D = leptin (1.2 nM) + DAPT (20 µM). S = small tumorsphere; M = medium tumorsphere; Lg = large tumorsphere; P2 = secondary passage; P3 = tertiary passage; UD = undetectable.
Supplementary
Note: Higher % of cells from tumorspheres express PCSC markers compared to adherent cells grown in basal conditions. PCSC markers were determined by flow cytometry analysis and the experiments were performed in triplicate.
